MPC vs PACB · P/E 16, rev $138.86B vs rev $38.4M
Marathon Petroleum Corp (MPC) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. PACB currently screens at market cap $387.1M.
Not investment advice. Open the MPC and PACB stock pages for the full models.
Not investment advice.